Delivery Order SPE2DB20D1110-SPE2DB25FK09M

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $2.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $53,304.56, is for the supply of Fingolimod 0.5 mg capsules to support military treatment facilities and federal healthcare programs. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other agencies, collectively valued at up to $999,999,999, that allow the government to efficiently...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,053.12 firm fixed-price contract is for the delivery of the drug Fingolimod 0.5 mg capsules, with a period of performance through March 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $5,489.88 and has a performance period through January 27, 2025. It is for the procurement of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,817.40 firm-fixed-price contract is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a medication used to treat certain medical conditions. The contract has an ultimate completion date of January 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules. The contract has a ceiling value of $2,143.36 and an ultimate completion date of September 19, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a broad range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,906.06, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of January 28, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $15,466.57, is a delivery order with a firm fixed price for the supply of 4567796101 - FINGOLIMOD 0.5 MG CAPSULE 30S. The contract has an ultimate completion date of April 4, 2025. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026,...
This federal contract award, with ID SPE2DB22D2214|SPE2DB25FS4PK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,609.58 firm fixed-price delivery order is for the supply of 4,567,874,718 units of the medication Fingolimod 0.5 mg capsules. The contract has an ultimate completion date of April 11, 2025 and was awarded on April 10, 2025. This delivery order is part of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564377288 units of Fingolimod 0.5 mg capsules. The contract, valued at $33,275.45, was awarded on April 23, 2024 by the Defense Logistics Agency Troop Support Medical, with a completion date of April 24, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,526.70 Firm Fixed Price Delivery Order covers the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB25FK09M
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,811.90, is for the delivery of Fingolimod 0.5 mg capsules. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 21, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/18/25, 9:47 AM